Inhibikase Therapeutics, Inc. (IKT), a biopharmaceutical company with a market capitalization of $189.48 million, has announced the halting of further development of its Parkinson's disease drug, ...

A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month ...

U.S. Department of Defense awards $4 million to researchers at OHSU, University of Washington, VA Portland, VA Puget Sound to ...

Stop the Spread. Injecting saline into mouse kidneys did not affect the left or right substantia nigra (top). Injecting fibrils of α-synuclein ablated about half of the dopaminergic neurons (middle ...

In a significant advancement for Parkinson’s Disease (PD) therapy, researchers have developed a targeted nano formulation ...

Hearing impairment has emerged as a potential risk factor for Parkinson’s disease, a progressive neurodegenerative disorder that primarily manifests with motor impairments like tremors, rigidity, and ...

Past studies on mice found Lag3 binds to alpha-synuclein proteins and spreads Parkinson's disease pathology in neurons. While ...

The goal of the MCBDTP is to train PhD and MD/PhD scientists who will advance research in experimental Pathology and the molecular and cellular basis of disease. The MCBDTP provides a PhD training ...

Parkinson’s disease (PD) may lead to an increased risk of developing severe illness and a more complicated recovery from a COVID-19 infection. Generally, respiratory infections such as pneumonia can ...

Phil Parkinson has previously managed Colchester United, Hull City, Charlton Athletic, Bradford City, Bolton Wanderers and Sunderland Speaking before his 1,000th game as manager, Wrexham boss Phil ...